Slide 1Future directions for CKD anaemia Iain C Macdougall BSc, MD, FRCP Consultant Nephrologist and Honorary Senior Lecturer Renal Unit, King’s College Hospital, London,…

1.Ethical and Scientific Issuesin the use of Human Stem Cells Allen R. Dyer, M.D., Ph.D. [email_address] http://faculty.etsu.edu/dyer2. Legal Scientific Religious Ethical…

1. Human Inferior Turbinate : An Alternative Tissue Source of Multipotent Mesenchymal Stromal Cells Presenter –Madan Gupta Guide –Prof S C Sharma 2. INTRODUCTION …

1. Myeloproliferative Disorders 2. Overview The Myeloproliferative disorders: Polycythemia vera Essential Thrombocytosis Myelofibrosis CML 3. Polycythemia An elevation in…

1. Myeloproliferative Disorders 2. Overview The Myeloproliferative disorders: Polycythemia vera Essential Thrombocytosis Myelofibrosis CML 3. Polycythemia Erythrocytosis…

1. Stem cell technologies Current state Future promise Where UCI fits in to the Post Prop. 71 world of biotechnology development in California 2. Proposition 71: Purpose…

1. Visualization of life science research by using MeSH and GIS techniques Masashi Shirabe 2. This work is done as a part of the project “Scientometrics conducive…

1. 1 Chronic Leukemia 2. What Are the Types of Chronic Leukemia? 2 3. Classification of CL. 3  There are two types:  1-chronic myeloid leukemia.  2-chronic lymphoid…

1. • Level or stage of neural maturation differentially effected susceptibility to neurotoxins. • Metabolomic profiling provides a sensitive pathway analysis approach…

1. Patient-specific induced pluripotent stem cells (iPSCs) for the study and treatment of retinal degenerative diseases Luke A. Wiley a, 1, 2 , Erin R. Burnight a, 1, 2…